The annual JP Morgan Health Conference is here. At this year's conference, Illumina is expected to launch a new sequencing series, NovaSeq, with its "unparalleled throughput, simple operation, low cost and flexibility", which is expected to reduce the cost of genome sequencing to $100. NovaSeq will be the strongest sequencer from Illumina to meet the researchers' higher requirements for sequencing depth and to reduce the difficulty of large-scale sequencing projects. The instrument can sequence the entire genome of 3-48 people in one operation, providing powerful help for analyzing rare genetic variants associated with complex diseases. Human Longevity co-founder and executive chairman J. Craig Venter said: “I am very pleased that Novaseq can join our sequencing center and use it with existing HiSeq X. Efficient, low-cost and innovative sequencing technologies can drive breakthroughs in precision medicine. The new platform will help us expand our database. Get the most comprehensive genomic data, phenotypic data and clinical data." Richard Gibbs, founder of the Human Genome Sequencing Center at Baylor College of Medicine in the United States, said: "The focus of NovaSeq is clinical. We are looking forward to the birth of tens of thousands of human genome data." Regeneron Genetics Center Aris Baras believes: "In the past few years, the Regeneron Genetics Center has sequenced more than 150,000 exomes. Novaseq is expected to further improve our sequencing efficiency and output. We believe that the cause is to advance treatment at the genetic level. The essential." Francis de Souza, President and CEO of Illumina, introduced: "The launch of Novaseq is an important chapter in the history of Illumina's innovation. In 2010, our HiSeq X-series platform enabled the sequencing of $1,000 for genomes. We believe that Novaseq enables the genome to be sequenced into the $100 era, which will give scientists a deeper understanding of complex diseases and bring better treatment options. Novaseq can undertake genetic research on an unprecedented scale, reducing sequencing costs. It is conceivable that in the future, all people will benefit from precision medicine . The new system is suitable for laboratories that cannot afford the HiSeqX system but plan for human genome-wide sequencing projects. Food Additive,Natural Food Additives,Acid Food Additives,Food Grade Additive Allied Extracts Solutions , https://www.alliedadditives.com
